Status:

COMPLETED

Efficacy and Safety of the Minimed 780G® Advanced Hybrid Closed Loop System (AHCL) in Patients With Type 1 Diabetes Undergoing Surgery

Lead Sponsor:

Hospital Universitario San Ignacio

Collaborating Sponsors:

Pontificia Universidad Javeriana

Conditions:

Type 1 Diabetes (T1D)

Surgery, Day

Eligibility:

All Genders

18+ years

Brief Summary

An analytical observational study based on a cohort of patients who received training at San Ignacio University Hospital. Glycemic control metrics were compared between the perioperative and postopera...

Detailed Description

Patients using the Minimed 780G device who completed training and clinical follow-up in the Endocrinology Unit of San Ignacio University Hospital. Through the clinical follow-up established by the uni...

Eligibility Criteria

Inclusion

  • Patients older than 18 years AHCL (Minimed 780G) users undergoing elective and urgent surgery during the study period.

Exclusion

  • Patients whose pump use was discontinued during the perioperative period. Pregnant patients. Patients without sensor data in the 2 weeks before and after surgery.

Key Trial Info

Start Date :

August 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 30 2025

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT06947031

Start Date

August 1 2023

End Date

April 30 2025

Last Update

September 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario San Ignacio

Bogota, Cundinamarca, Colombia, 860.015.536-1

Efficacy and Safety of the Minimed 780G® Advanced Hybrid Closed Loop System (AHCL) in Patients With Type 1 Diabetes Undergoing Surgery | DecenTrialz